(Q53257577)

12 May 2018

title

p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma. (English)

1 reference

12 May 2018

author

Robert Eferl

11

1 reference

12 May 2018

Richard Moriggl

12

1 reference

12 May 2018

Wolfgang Mikulits

13

1 reference

12 May 2018

author name string

Doris Schneller

1

1 reference

12 May 2018

Georg Machat

2

1 reference

12 May 2018

Alexandra Sousek

3

1 reference

12 May 2018

Verena Proell

4

1 reference

12 May 2018

Franziska van Zijl

5

1 reference

12 May 2018

Gudrun Zulehner

6

1 reference

12 May 2018

Heidemarie Huber

7

1 reference

12 May 2018

Markus Mair

8

1 reference

12 May 2018

Markus K Muellner

9

1 reference

12 May 2018

Sebastian M B Nijman

10

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 July 2011

1 reference

12 May 2018

published in

Hepatology

1 reference

12 May 2018

volume

54

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

164-172

1 reference

12 May 2018

1 reference

The STATs of cancer--new molecular targets come of age

21 January 2018

1 reference

21 January 2018

1 reference

Of alphas and betas: distinct and overlapping functions of STAT3 isoforms

21 January 2018

1 reference

STAT3: a multifaceted oncogene

21 January 2018

1 reference

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway

21 January 2018

1 reference

The dark and the bright side of Stat3: proto-oncogene and tumor-suppressor

21 January 2018

1 reference

Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice

21 January 2018

1 reference

Liver regeneration: from myth to mechanism

21 January 2018

1 reference

NF-κB and STAT3 - key players in liver inflammation and cancer

21 January 2018

1 reference

Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance

21 January 2018

1 reference

Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.

21 January 2018

1 reference

Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma

21 January 2018

1 reference

Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma

21 January 2018

1 reference

The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling.

21 January 2018

1 reference

Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation

21 January 2018

1 reference

Roles of unphosphorylated STATs in signaling

21 January 2018

1 reference

Cancer gene discovery in hepatocellular carcinoma

21 January 2018

1 reference

Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer

21 January 2018

1 reference

The promiscuity of ARF interactions with the proteasome.

21 January 2018

1 reference

Divorcing ARF and p53: an unsettled case

21 January 2018

1 reference

INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.

21 January 2018

1 reference

P14ARF gene alterations in human hepatocellular carcinoma.

21 January 2018

1 reference

Immortalized p19ARF null hepatocytes restore liver injury and generate hepatic progenitors after transplantation.

21 January 2018

1 reference

3,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model.

21 January 2018

1 reference

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

21 January 2018

1 reference

PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression.

21 January 2018

1 reference

Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes

21 January 2018

1 reference

Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells

21 January 2018

1 reference

The INK4a/ARF network in tumour suppression

21 January 2018

1 reference

Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.

21 January 2018

1 reference

Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA.

21 January 2018

1 reference

Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness.

21 January 2018

1 reference

Mitochondrial STAT3 supports Ras-dependent oncogenic transformation.

21 January 2018

1 reference

Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression.

21 January 2018

1 reference

Mutational analysis of JAK1 gene in human hepatocellular carcinoma

21 January 2018

1 reference

Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy

21 January 2018

1 reference

Signal Transducer and Activator of Transcription 3 Protects From Liver Injury and Fibrosis in a Mouse Model of Sclerosing Cholangitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HEP.24329

1 reference

12 May 2018

1 reference

12 May 2018